SCHEMBL891896

SCHEMBL891896

CC(C)(C)OC(=O)NC1(CCN)CCOCC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 2/20 0.34
CTSD P07339 1/20 0.34
CTSB P07858 1/20 0.34
CTSS P25774 1/20 0.34
USP2 O75604 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HCRTR2 O43614 1/20 0.33
MEN1 O00255 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
GAA P10253 1/20 0.32
P2RX7 Q99572 1/20 0.32
CTSK P43235 2/20 0.32
APLNR P35414 1/20 0.31
GHSR Q92847 1/20 0.31
AAK1 Q2M2I8 1/20 0.31
TDP1 Q9NUW8 1/20 0.30
DPP8 Q6V1X1 1/20 0.30
DPP9 Q86TI2 1/20 0.30
CD274 Q9NZQ7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3364824 0.89 MEN1 (0.36) CTSLMEN1MAPK1KMT2AGAA
SCHEMBL14851185 0.88 CTSL (0.36) CTSLCTSDCTSBCTSSUSP2
Hydrochloric Acid SCHEMBL30426524 0.88 MEN1 (0.35) CTSLMEN1MAPK1KMT2AGAA
SCHEMBL1692918 0.87 CTSL (0.38) CTSLCTSDCTSBCTSSUSP2
SCHEMBL3365305 0.86 P2RX7 (0.40) CTSLMEN1MAPK1KMT2AGAA
SCHEMBL25574885 0.86 P2RX7 (0.38) CTSLMEN1MAPK1KMT2AGAA
SCHEMBL5538732 0.84 CTSL (0.34) CTSLCTSDCTSBCTSSUSP2
SCHEMBL19388519 0.83 USP2 (0.37) CTSLCTSDCTSBCTSSUSP2
SCHEMBL1667225 0.83 CTSL (0.39) CTSLCTSDCTSBCTSSUSP2
SCHEMBL14852887 0.82 GAA (0.35) CTSLCTSDCTSBCTSSUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120083489-A1 BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISTS GLAXOSMITHKLINE LLC 2012-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120083489-A1 BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISTS MCHR1, MCHR2, MC1R CTSL 3882/4885CTSD 4182/4885CTSB 3003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.